Literature DB >> 9605430

Inhibitory effect of mast cell-mediated immediate-type allergic reactions in rats by spirulina.

H M Kim1, E H Lee, H H Cho, Y H Moon.   

Abstract

We investigated the effect of spirulina on mast cell-mediated immediate-type allergic reactions. Spirulina dose-dependently inhibited the systemic allergic reaction induced by compound 48/80 in rats. Spirulina inhibited compound 48/80-induced allergic reaction 100% with doses of 100-1000 microg/g body weight, i.p. Spirulina (10-1000 microg/g body weight, i.p.) also significantly inhibited local allergic reaction activated by anti-dinitrophenyl (DNP) IgE. When rats were pretreated with spirulina at a concentration ranging from 0.01 to 1000 microg/g body weight, i.p., the serum histamine levels were reduced in a dose-dependent manner. Spirulina (0.001 to 10 microg/mL) dose-dependently inhibited histamine release from rat peritoneal mast cells (RPMC) activated by compound 48/80 or anti-DNP IgE. The level of cyclic AMP in RPMC, when spirulina (10 microg/mL) was added, transiently and significantly increased about 70-fold at 10 sec compared with that of control cells. Moreover, spirulina (10 microg/mL) had a significant inhibitory effect on anti-DNP IgE-induced tumor necrosis factor-alpha production. These results indicate that spirulina inhibits mast cell-mediated immediate-type allergic reactions in vivo and in vitro.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9605430     DOI: 10.1016/s0006-2952(97)00678-3

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  14 in total

1.  Induction of heme oxygenase-1 by phenylarsine oxide. Studies in cultured primary liver cells.

Authors:  O S Gildemeister; J A Pepe; R W Lambrecht; H L Bonkovsky
Journal:  Mol Cell Biochem       Date:  2001-10       Impact factor: 3.396

Review 2.  Hypolipidemic, antioxidant, and antiinflammatory activities of microalgae Spirulina.

Authors:  Ruitang Deng; Te-Jin Chow
Journal:  Cardiovasc Ther       Date:  2010-08       Impact factor: 3.023

3.  The effects of spirulina on allergic rhinitis.

Authors:  Cemal Cingi; Meltem Conk-Dalay; Hamdi Cakli; Cengiz Bal
Journal:  Eur Arch Otorhinolaryngol       Date:  2008-03-15       Impact factor: 2.503

4.  Evaluation of protective efficacy of Spirulina platensis against collagen-induced arthritis in rats.

Authors:  Narendra Kumar; Surendra Singh; Nisha Patro; Ishan Patro
Journal:  Inflammopharmacology       Date:  2009-04-24       Impact factor: 4.473

5.  Inhibitory effects of dietary Spirulina platensis on UVB-induced skin inflammatory responses and carcinogenesis.

Authors:  Flandiana Yogianti; Makoto Kunisada; Eiji Nakano; Ryusuke Ono; Kunihiko Sakumi; Sugako Oka; Yusaku Nakabeppu; Chikako Nishigori
Journal:  J Invest Dermatol       Date:  2014-04-14       Impact factor: 8.551

6.  Role of histamine in the inhibitory effects of phycocyanin in experimental models of allergic inflammatory response.

Authors:  D Remirez; N Ledón; R González
Journal:  Mediators Inflamm       Date:  2002-04       Impact factor: 4.711

7.  Consequences of AphanizomenonFlos-aquae(AFA) extract (Stemtech (TM) ) on metabolic profile of patients with type 2 diabetes.

Authors:  Maryam Sanaei; Mehdi Ebrahimi; Zahra Banazadeh; Gita Shafiee; Fatemeh Khatami; Zeinab Ahadi; Ramin Heshmat
Journal:  J Diabetes Metab Disord       Date:  2015-06-24

8.  CD59 underlines the antiatherosclerotic effects of C-phycocyanin on mice.

Authors:  Bing Li; Xian-Ming Chu; Ying-Jie Xu; Fan Yang; Cong-Yi Lv; Shu-min Nie
Journal:  Biomed Res Int       Date:  2013-11-12       Impact factor: 3.411

9.  Effect of spirulina and chlorella alone and combined on the healing process of diabetic wounds: an experimental model of diabetic rats.

Authors:  Naeim Mehdinezhad; Naheed Aryaeian; Mohammadreza Vafa; Atoosa Saeedpour; Abdolali Ebrahimi; Tofigh Mobaderi; Reza Fahimi; Zohreh Sajadi Hezaveh
Journal:  J Diabetes Metab Disord       Date:  2021-01-19

10.  Spirulina in clinical practice: evidence-based human applications.

Authors:  P D Karkos; S C Leong; C D Karkos; N Sivaji; D A Assimakopoulos
Journal:  Evid Based Complement Alternat Med       Date:  2010-10-19       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.